Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 25, Issue 5, Pages 333-339
Publisher
Wiley
Online
2016-01-19
DOI
10.1111/exd.12948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secretion, blood levels and cutaneous expression of TL1A in psoriasis patients
- (2015) Anders Elm Pedersen et al. APMIS
- Active nuclear IKK correlates with metastatic risk in cutaneous squamous cell carcinoma
- (2015) Agusti Toll et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis
- (2015) Line V. Iversen et al. BMC MUSCULOSKELETAL DISORDERS
- Potential serum biomarkers of treatment response to ustekinumab in patients with psoriasis: a pilot study
- (2015) A.J. Onderdijk et al. BRITISH JOURNAL OF DERMATOLOGY
- Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas
- (2015) Ellen H. de Moll et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Biomarkers for atopic dermatitis
- (2015) Judith Thijs et al. Current Opinion in Allergy and Clinical Immunology
- Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
- (2015) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions
- (2015) Angelo Massimiliano D'Erme et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
- (2015) Iria V. Seoane et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
- (2015) M Arock et al. LEUKEMIA
- A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus
- (2015) C Calderon et al. LUPUS
- Industry–academia collaborations for biomarkers
- (2015) Khusru Asadullah et al. NATURE REVIEWS DRUG DISCOVERY
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
- (2015) Alsya J. Affandi et al. Seminars in Immunopathology
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
- (2015) Markus Morkel et al. Oncotarget
- New Developments in Biomarkers for Atopic Dermatitis
- (2015) Judith Thijs et al. Journal of Clinical Medicine
- Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics
- (2015) Yasaman Mansouri et al. Journal of Clinical Medicine
- Personalized therapy for breast cancer
- (2014) F.B. De Abreu et al. CLINICAL GENETICS
- Precision medicine and skin cancer therapy
- (2014) Reinhard Dummer CURRENT OPINION IN ONCOLOGY
- Vitiligo treatment demystified: a flowchart for stratified treatment approaches
- (2014) Rebecca Tung et al. EXPERIMENTAL DERMATOLOGY
- Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient
- (2014) Tag S. Anbar et al. EXPERIMENTAL DERMATOLOGY
- Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation
- (2014) H. Salter et al. JOURNAL OF INTERNAL MEDICINE
- Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials
- (2014) Keith T Flaherty et al. LANCET ONCOLOGY
- Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
- (2014) Gamze Erfan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Predictive Safety Testing Consortium and the Coalition Against Major Diseases
- (2014) Diane Stephenson et al. NATURE REVIEWS DRUG DISCOVERY
- The Biomarkers Consortium
- (2014) David Wholley NATURE REVIEWS DRUG DISCOVERY
- Grants4Targets: an open innovation initiative to foster drug discovery collaborations
- (2014) Heidrun Dorsch et al. NATURE REVIEWS DRUG DISCOVERY
- Breast tumor subgroups reveal diverse clinical prognostic power
- (2014) Zhaoqi Liu et al. Scientific Reports
- The current status of biomarkers for predicting toxicity
- (2013) Sarah Campion et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacogenomic biomarkers for personalized medicine
- (2013) James J Chen et al. PHARMACOGENOMICS
- The Long and Winding Regulatory Road for Laboratory-Developed Tests
- (2012) Ronald L. Weiss AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Insight into newly discovered innate immune modulation in atopic dermatitis
- (2012) Chang Ook Park et al. EXPERIMENTAL DERMATOLOGY
- Studies on serum 8-hydroxy guanosine (8-OHdG) as reliable biomarker for psoriasis
- (2012) K.H. Basavaraj et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A call for transparent reporting to optimize the predictive value of preclinical research
- (2012) Story C. Landis et al. NATURE
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Bring on the biomarkers
- (2011) George Poste NATURE
- Crowd sourcing in drug discovery
- (2011) Monika Lessl et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II failures: 2008–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Believe it or not: how much can we rely on published data on potential drug targets?
- (2011) Florian Prinz et al. NATURE REVIEWS DRUG DISCOVERY
- Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
- (2010) J. E. Dancey et al. CLINICAL CANCER RESEARCH
- Melanoma staging: Facts and controversies
- (2010) Andrea Forschner et al. CLINICS IN DERMATOLOGY
- Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy
- (2009) J.S. Ross DRUG NEWS & PERSPECTIVES
- Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
- (2009) K Nakai et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
- (2009) Patrick A. M. Jansen et al. PLoS One
- Plasma TGF-β1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity
- (2008) Iwona Flisiak et al. BIOMARKERS
- Validation of Analytic Methods for Biomarkers Used in Drug Development
- (2008) C. H. Chau et al. CLINICAL CANCER RESEARCH
- Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis
- (2008) Wolf-Dietrich Döcke et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started